8-K
filed August 4, 2022, 7:59 PM ET
ticker COCH
CIK 0001840877
leadership
confidence high
sentiment negative
materiality 0.85
Anzu Special Acquisition loses CFO, GC, two board members including chair; Nasdaq non-compliance triggered
Envoy Medical, Inc.
- CFO John Joy and GC Peter Ganz resigned July 29-31, 2022; Joy effective after Q2 10-Q filing, Ganz effective July 31.
- Board members Teresa Harris (July 29) and Chairman William Wulfsohn (July 31) resigned citing disagreement with company decisions, pursuit of a specific target, and loss of executives.
- Resignations reduce board from 5 to 3; Nasdaq notified of non-compliance with audit committee independence rule (Listing Rule 5605(c)(2)(A)).
- Company has no pending letter of intent and no assurance of completing a business combination; cure period available for Nasdaq compliance.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
John W. Joy resigned as Chief Financial Officer at Envoy Medical, Inc..
- Action
- resigned
- Role
- Chief Financial Officer
Exact text from the filing
On July 29, 2022, John W. Joy notified the Company of his intention to resign from his position as Chief Financial Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
William Wulfsohn resigned as Chairman of the Board at Envoy Medical, Inc..
- Action
- resigned
- Role
- Chairman of the Board
Exact text from the filing
On July 31, 2022, William Wulfsohn notified the Company of his resignation as a member of the Board effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Peter J. Ganz resigned as General Counsel & Corporate Secretary at Envoy Medical, Inc..
- Action
- resigned
- Role
- General Counsel & Corporate Secretary
Exact text from the filing
On July 29, 2022, Peter J. Ganz notified the Company of his resignation from his position as General Counsel & Corporate Secretary of the Company effective July 31, 2022.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Teresa A. Harris resigned as Director at Envoy Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
On July 29, 2022, Teresa A. Harris notified the Company of her resignation as a member of the Board effective immediately.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.